Beneficial Effect of Low Phosphorus Diet in Uraemic Rats: A Reappraisal

1982 ◽  
Vol 63 (6) ◽  
pp. 539-548 ◽  
Author(s):  
Denise Laouari ◽  
Claire Kleinknecht ◽  
Giulia Cournot-Witmer ◽  
Renée Habib ◽  
Françoise Mounier ◽  
...  
Keyword(s):  
Renal Function ◽  
Beneficial Effect ◽  
Deficient Diet ◽  
Renal Deterioration ◽  
Total Food Intake ◽  
Total Food ◽  
High Calcium ◽  
Renal Histology ◽  
Low Phosphorus ◽  
Group B

1. Diets deficient in phosphorus have been shown to preserve the renal function of uraemic rats, but the role of concomitant alterations in the intake of other nutrients caused by such diets was not elucidated. 2. Five groups of uraemic rats were compared. Three (A, B, C) received (ad libitum) diets deficient (0·03%), low (0·2%) or normal (0·5%) in P. Two groups (D, E) received restricted amounts of 0·2% and 0·5% P diets by pair-feeding with group A rats. 3. Phosphorus deficient diet resulted in marked anorexia, growth arrest, low P and high calcium plasma levels and severe rickets, but renal function became stabilized. Groups B and C had both higher total food intake and weight gain but a significantly higher mortality rate. After 36 weeks, mortality was 90% in these groups, and was 19%, 28% and 44% in groups A, D and E rats respectively, despite a higher P consumption in group E than in group B rats. 4. Normal P diet was associated with severe renal calcium deposits and high calcium heart content, which were related to the degree of hyperparathyroidism evaluated by bone histology. 5. Preservation of renal function was mainly mediated by reduction in some other components of the diet and not by P restriction itself. Normal P diet with restricted dietary allotments had little adverse effect on survival, and its influence on renal histology is not easy to explain. 6. Restriction in P sufficient to cause moderate hypophosphataemia, disappearance of phosphaturia and to prevent hyperparathyroidism without causing anorexia and other severe side effects, had little or no beneficial effect on renal deterioration.

scholarly journals Dietary fish oil in renal transplant recipients treated with cyclosporin-A: no beneficial effects shown.

1996 ◽  
Vol 7 (3) ◽  
pp. 513-518
Author(s):  
M F Kooijmans-Coutinho ◽  
J Rischen-Vos ◽  
J Hermans ◽  
J W Arndt ◽  
F J van der Woude
Keyword(s):  
Blood Pressure ◽  
Renal Function ◽  
Beneficial Effect ◽  
Fish Oil ◽  
Cyclosporin A ◽  
Graft Function ◽  
Renal Transplant Recipients ◽  
Omega 3 ◽  
Double Blind ◽  
Renal Histology

This study aimed to determine whether dietary supplementation with fish oil has a beneficial effect on graft function and the incidence of rejection in renal allograft recipients treated with cyclosporin A (CsA). Renal function, blood pressure, the incidence of acute rejection episodes, graft survival, and renal histology and immunochemistry were investigated. In a randomized, placebo-controlled, double-blind trial, groups of 25 recipients of primary cadaveric renal allografts who had been treated with CsA took fish oil (30% C20:5 omega-3 and 20% C22:6 omega-3) or coconut oil (63% C8:0 and 36% C10:0) at 6 g/day for 3 months. There were no differences between the two patient groups with regard to HLA matching, panel-reactive antibody titers, or the demographic characteristics of donors or recipients. The GFR and effective RPF were determined at 1, 3, and 12 months after transplantation by simultaneous measurement of (125I-)iothalamate and (131I-)hippuran clearances. At 1 yr after transplantation, patients treated with fish oil showed better renal function than did the control patients, but this difference was not statistically significant. Blood pressure and antihypertensive drug use were similar in both groups. The number of rejection episodes was also similar, and renal histopathological and immunohistochemical studies showed no significant differences between the fish-oil group and the control patients. It is concluded that fish oil, at a dose of 6 g/day, has no beneficial effect after renal transplantation within the time scale of the study.

THE ROLE OF THE PARATHYROID GLANDS IN THE ABSORPTION OF CALCIUM FROM THE SMALL INTESTINE

1970 ◽  
Vol 47 (1) ◽  
pp. 65-72 ◽  
Author(s):  
M. WINTER ◽  
E. MORAVA ◽  
G. SIMON ◽  
J. SÓS
Keyword(s):  
Small Intestine ◽  
Calcium Absorption ◽  
Normal Diet ◽  
Calcium Excretion ◽  
Deficient Diet ◽  
High Calcium ◽  
Low Phosphorus ◽  
Loop Technique

SUMMARY The absorption of calcium from duodenal and jejunal segments of the small intestine was studied in rats using an in-vivo loop technique. Previous parathyroidectomy decreased calcium absorption from both segments in rats fed a normal diet. Reduced calcium transport was greater in rats fed a calcium-deficient diet after parathyroidectomy. The slower clearance of radioactive calcium from the lumen of the intestine was not due to increased endogenous calcium excretion. Thyroidectomy, either alone or combined with parathyroidectomy, decreased calcium absorption but the effect of thyroidectomy alone requires further study. The decrease in calcium absorption after removal of the parathyroids was minimal or absent when the animals were fed a high calcium, low phosphorus, vitamin D-deficient diet or fasted 48 hr. before the experiment.

Association in horses of orosensory characteristics of foods with their post-ingestive consequences

2002 ◽  
Vol 75 (2) ◽  
pp. 257-265 ◽  
Author(s):  
M. C. Cairns ◽  
J. J. Cooper ◽  
H. P. B. Davidson ◽  
D. S. Mills
Keyword(s):  
Lower Energy ◽  
Nutrient Content ◽  
Nutritional Composition ◽  
Choice Test ◽  
Caloric Test ◽  
Total Food Intake ◽  
Total Food ◽  
Group A ◽  
Group B ◽  
Caloric Tests

AbstractIn the domestic environment, horses are often presented with foods to which they are not evolutionarily adapted, such as low fibre pellets. Horses may not have the ability to learn the consequences of consuming unnatural foodstuffs and adapt their selection accordingly. This study aimed to investigate the horse’s feeding preferences when presented with concentrate pellets differing in nutrient content. Using a choice test, the relative preferences of 12 horses for mint and garlic, in iso-caloric diets, was first assessed over 29 meals. A mint preference, calculated as the proportion of mint in the total food intake, was shown by 11 horses. The horses were then divided into two groups, approximately balanced on the basis of mint preference. Group A was exposed to a choice of a mint-flavoured lower energy food or a garlic-flavoured higher energy food, while group B was exposed to mint-flavoured higher energy food and garlic-flavoured lower energy food for 29 meals. Next the flavours were presented in iso-caloric foods, initially for 10 meals, then a further 40, before the flavour-energy pairings were reversed for 30 meals. A final iso-caloric test was carried out for 30 meals. Both groups showed a preference for mint in the initial iso-caloric choice test but no such preference was shown in later iso-caloric tests. Both groups showed a higher preference for mint when paired with higher energy (proportion of mint intake to total intake was 0·75 (s.e.0·02) and 0·73 (s.e.0·02) for A and B respectively). Group B also showed a preference for garlic when paired with higher energy (proportion of mint intake: 0·32, s.e. 0·02) whilst group A showed a significant decrease in preference for mint when paired with lower energy (by 0·21 (s.e. 0·03), T = 6·88, P 0·01). The results suggest that horses can select a higher energy diet over a lower energy one and that horses can form associations between foods and their nutritional composition, even if they do not resemble those found in their natural environment.

Protection of Renal Function and of Nutritional Status in Uremic Rats by Means of a Low-Protein, Low-Phosphorus Supplemented Diet

Nephron ◽  
1988 ◽  
Vol 49 (3) ◽  
pp. 197-202 ◽  
Author(s):  
G. Barsotti ◽  
L. Moriconi ◽  
A. Cupisti ◽  
L. Dani ◽  
F. Ciardella ◽  
...  
Keyword(s):  
Renal Function ◽  
Nutritional Status ◽  
Low Protein ◽  
Low Phosphorus

scholarly journals The effectivity of Difructose Anhydride III to increase absorption of calcium in the femur bone of calcium deficient rats

2020 ◽  
Vol 10 (4) ◽  
pp. 168
Author(s):  
Ainia Herminiati
Keyword(s):  
Calcium Concentration ◽  
Calcium Absorption ◽  
Bone Matrix ◽  
Sprague Dawley ◽  
Deficient Diet ◽  
Serum Calcium Concentration ◽  
Femur Bone ◽  
High Calcium ◽  
Matrix Condition ◽  
Dfa Iii

Background: Dried yogurt enriched by Difructose Anhydride III when used as a functional food has been observed to increase calcium absorption, making it useful in osteoporosis prevention. The objective of this study was to analyze the effectiveness of Difructose Anhydride III in increasing the absorption of calcium in female rat models, strain Sprague Dawley, in the pre-menopausal age during which they’re calcium deficient.Methods: The effectiveness test of Difructose Anhydride III to increase absorption of calcium in pre-menopausal Sprague Dawley rats was performed in calcium-deficient conditions. A completely randomized experimental design was used with 4 treatments for 6 weeks and 4 replications: normal rats fed with purified diet (C), calcium-deficient rats fed with calcium-deficient diet (CD), calcium-deficient rats fed with calcium-deficient diet and DFA III (dahlia tubers) fortified in dry yogurt (CD+DFA III dahlia), and calcium-deficient rats fed with a calcium-deficient diet and DFA III (chicory roots) fortified in dry yogurt (CD+DFA III chicory). The parameters measured were serum calcium concentration, femur bone calcium concentration, femur bone matrix condition, and femur bone strength.Results: DFA III (dahlia tubers and chicory roots) fortified in dry yogurt contained 0.334% and 0.322% of calcium concentration. The provision of a calcium-deficient diet for 12 weeks was shown to reduce the serum calcium concentration of the deficient calcium rat to 7.72±1.08 mg dL-1 and the control rat to 11.60±0.85 mg dL-1. CD+DFA III chicory treatments also showed a high calcium concentration in the femur bone (34.94±3.21%), a relatively higher bone strength (9.34±3.61 kg cm-2), and a denser femur bone matrix condition than the control. The femur bone calcium level of rats treated with CD+DFA III dahlia and chicory tubers was 28.95±1.95% and 34.94±3.21%, respectively. These results were significantly different than the CD treatment (17.49±4.38%).Conclusion: The evidence from this study suggests that sufficient calcium intake could provide high calcium deposits in the bones. Diets containing 3.60% w/w DFA III fortified in dry yogurt have been shown to enhance calcium absorption in calcium-deficient rats. Additionally, the effectiveness of dried yogurt enriched by DFA III from chicory tubers was higher than that of the dried yogurt enriched by DFA III from dahlia tubers.Preclinical Trial Registration: Animal Ethics Committee at IPB University No. 12-2013Keywords: Bone femur; calcium deficiency; effectivity of Difructose Anhydride III

The association of renal function with safety and efficacy of cisplatin plus S-1 (CS) therapy and docetaxel plus cisplatin plus S-1 (DCS) therapy in patients with advanced gastric cancer (AGC): An additional analysis of JCOG1013.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e16035-e16035
Author(s):  
Shuichi Hironaka ◽  
Ryo Sadachi ◽  
Nozomu Machida ◽  
Satoru Iwasa ◽  
Yasuhide Yamada ◽  
...  
Keyword(s):  
Renal Function ◽  
Adverse Events ◽  
Objective Response ◽  
Exploratory Analysis ◽  
Phase Iii ◽  
Fixed Dose ◽  
Hematological Toxicity ◽  
Significant Difference ◽  
Group A ◽  
Group B

e16035 Background: A phase III study, JCOG1013, did not show the superiority of docetaxel plus cisplatin plus S-1 (DCS) to cisplatin plus S-1 (CS) in overall survival (OS) (Yamada Y, Lancet GH 2019). It is known that cisplatin and gimeracil (an inhibitor of dihydropyrimidine dehydrogenase contained in S-1) are excreted in urine. We previously reported (abstr 197, ASCO-GI 2021) exploratory analysis of JCOG1013 which showed creatinine clearance (CrCl) was associated with safety (Grade [G]4 hematological toxicity for CS, and G3-4 non-hematological toxicity for CS and DCS), but not with efficacy in either group. Here, we report the additional detail results of this exploratory analysis. Methods: Among 741 participants in JCOG1013, patients with serum creatinine level < 1.2 mg/dL were included in this analysis and categorized by CrCl and treatment into A1 (CrCl ≥ 80 mL/min, CS), A2 (60 < CrCl < 80, CS), A3 (CrCl < 60, CS), B1 (CrCl > 80, DCS), B2 (60 < CrCl < 80, DCS), and B3 (CrCl < 60, DCS). The dose (mg/m2) of C/S was 60/80 regardless renal function in group A (A1, A2 and A3), and that of D/C/S was adjusted in group B as follows: 40/60/80 in B1, 40/50/80 in B2, and 40/40/65 in B3. Adverse events, OS, progression-free survival (PFS), and objective response rate (ORR) were compared by CrCl in group A (A1 vs. A2 vs. A3) and group B (B1 vs B2 vs B3), respectively. Results: Of 723 pts (169/136/57 in A1/A2/A3 and 170/138/53 in B1/B2/B3), the median CrCl (mL/min) was 94.1/71.9/53.4 in A1/A2/A3 and 98.2/70.0/55.6 in B1/B2/B3. The relative dose intensity of C/S was 90.4/75.3%, 87.8/74.9% and 85.7/72.8% in A1, A2 and A3, and that of D/C/S was 87.5/77.7/74.9%, 85.8/61.2/72.7% and 87.8/49.4/58.3% in B1, B2 and B3. The incidence of G4 white blood cell decreased, G4 neutrophil count decreased, and G3-4 anorexia were 1.2/4.4/9.3% (P < 0.01), 4.8/11.1/18.5% (P < 0.01), 14.4/28.1/28.6% (P < 0.01) in A1/A2/A3, and 1.8/3.0/4.0% (P = 0.36), 27.3/24.8/20.0% (P = 0.28), 22.4/29.3/32.0% (P = 0.11) in B1/B2/B3, respectively. No significant association between CrCl and other adverse events was observed either in CS or in DCS group. The median OS was 15.4/15.5/15.4 months in A1/A2/A3 (P = 0.89) and 15.3/13.7/13.7 months in B1/B2/B3 (P = 0.72). The median PFS was comparable among A1/A2/A3 (7.1/6.8/6.2 months, P = 0.88) and B1/B2/B3 groups (7.5/7.2/7.8 months, P = 0.85). ORR showed no significant difference in A1/A2/A3 (58.9/57.8/46.9%, P = 0.31) and B1/B2/B3 groups (62.0/61.5/51.5%, P = 0.36). Conclusions: Dose modification according to renal function in the DCS arm could control the increase of severe toxicities, which were observed frequently in patients with low renal function in patients receiving fixed dose of CS. Clinical trial information: 000007652.

Effect of adrenalectomy and corticosterone replacement on meal patterns of Zucker rats

1985 ◽  
Vol 249 (5) ◽  
pp. R584-R594 ◽  
Author(s):  
M. R. Freedman ◽  
T. W. Castonguay ◽  
J. S. Stern
Keyword(s):  
Weight Gain ◽  
Food Intake ◽  
Body Weight Gain ◽  
Zucker Rats ◽  
Meal Frequency ◽  
Light Cycle ◽  
Dark Cycle ◽  
Meal Patterns ◽  
Total Food Intake ◽  
Total Food

Male obese and lean Zucker rats were adrenalectomized (ADX) or sham-operated at 10 wk of age. Approximately 16 wk later, patterns of food intake were monitored by computer-interfaced top loading balances. Data were collected from ADX rats before, during, and after access to a corticosterone-supplemented saline solution (20 micrograms/ml). Although total food intake during the precorticosterone treatment period was not different between ADX and sham controls, ADX resulted in attenuation of light cycle food intake, primarily via decreased meal frequency. With steroid replacement, light cycle meal frequency and food intake increased. Despite comparable self-administered dose (20.33 +/- 0.89 vs. 17.05 +/- 1.2 mg corticosterone/period, obese vs. lean), obese ADX rats were more responsive to steroid than were lean ADX rats. This increased responsiveness was reflected by a 30% increase in food intake and 60% increase in body weight gain of obese ADX rats during replacement. Lean ADX rats exhibited no change in total food intake or weight gain with replacement. Further, during corticosterone treatment, obese ADX rats increased meal frequency, total food intake, and consumption of large meals (greater than or equal to 4 g) during the dark cycle. Significant postprandial correlations were found only in obese ADX rats, both with and without replacement during the dark cycle. These results suggest adrenal glucocorticoids have a minimal effect on food intake and meal patterns in lean Zucker rats but significantly alter intake and meal patterns in obese rats.

Sign in / Sign up

Export Citation Format

Share Document